ArticleMolecular genetics and genomics : MGG2025
Weakened invasion of severe fever with thrombocytopenia syndrome bunyavirus beneficial to its immune escape by multi-site mutation of glycoprotein.
Article in Molecular genetics and genomics : MGG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Genotype-Specific Amino Acid Signatures in the Gn/Gc Glycoprotein of Severe Fever with Thrombocytopenia Syndrome Virus Associated with Neurological Symptoms.Pathogens (Basel, Switzerland) · 2026Article
- Antibody engineering for SFTS treatment: frontier progress and translational challenges.Frontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Severe fever with thrombocytopenia syndrome (SFTS) is a tick-borne infectious disease caused by severe fever with thrombocytopenia syndrome virus (SFTSV) which results in a high mortality rate and poses a public health threat. Gene variation of SFTSV is one of the major forces driving its persistence and widespread prevalence. However, how genetic variations affect virus invasion is not yet fully understood. In this study, we evaluated the adaptive advantage of three stable high-frequency substitutions D170N, I323V, and K619R located on the envelope glycoprotein of SFTSV based on 1041 M segments of their genomes. The result demonstrated that single mutation of D170N, or K619R reduced infectivity of mutant. However, the combined presence of both D170N, and K619R mutation enhanced infectivity of mutants. Structure model and SPR assay studies indicated that the substitution at the 170 site reduced the binding affinity between Gn glycoprotein and host C-C motif chemokine receptor 2 (CCR2). Additionally, neutralization assay showed I323/K619R mutant exhibited completely resistance to neutralizing antibodies pressure. This study reveals that SFTSV balances its entry ability by gene variation of different loci on its glycoprotein via a trade-off between Gn and Gc. In addition, a weakened invasion strategy facilitated by site mutations benefits its immune evasion. The findings provide mechanistic insights into its prevalence, thereby enabling early warnings for potential future outbreaks.
Indexed as
Identifiers
41273444What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.